New Delhi: Fearing a rise in prices of life-saving medicines, the government is reviewing its decision to withdraw customs duty exemption for the import of 74 drugs, including those for treating cancer, AIDS and haemophilia.
A notification issued last week by Central Board of Excise and Customs had announced that customs duty exemption on the import of 74 drugs was withdrawn.
"The matter (of withdrawal of exemption) is being reviewed," sources in the Health Ministry said.
The move is expected to make the treatment of a multitude of diseases costlier, including kidney stones, heart rhythm disorders, diabetes, Parkinson's disease, bone diseases, bacterial infections, anaesthetic medication, allergies, arthritis, lupus, menopause, glaucoma, poisoning by a chemical or pesticide, growth failure in children and ulcerative
colitis.
A notification issued last week by Central Board of Excise and Customs had announced that customs duty exemption on the import of 74 drugs was withdrawn.
"The matter (of withdrawal of exemption) is being reviewed," sources in the Health Ministry said.
colitis.
COMMENTS
Advertisement
Canada-Based Terrorist Lakhbir Landa's Key Aide Arrested India Sends First Tranche Of $2.5 Million For Palestinian Refugees US Scientists Decode 125-Year-Old Element That Could Improve Cancer Treatments Massive Worldwide Microsoft Outage: Flights, Markets, Stock Exchange Down CrowdStrike Falcon Sensor: The Culprit Behind World's Biggest IT Outage UPSC Cracks Down, Says Puja Khedkar Faked Identity, Parents' Name, Address Microsoft Outage "Affecting IT Operations" Paris Olympics Organisers Biden Or Trump, It's Still A Long Wait For Indian 'Dreamers' In US ISRO Chief Gets His PhD From IIT-Madras: "A Village Boy's Dream Fulfilled" Track Latest News Live on NDTV.com and get news updates from India and around the world.